BioXcel Therapeutics, Inc. (BTAI)

NCM – Real Time Price. Currency in USD

1.19

-0.01 (-0.83%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

642K

375K

Cost of goods sold

-464K

-2M

-347K

Gross Profit

178K

-186K

-198K

28K

Operating expenses (excl. COGS)

-50M

-63M

-166M

-158M

Operating Income

-50M

-63M

-166M

-158M

Non-operating income, total

-20M

-13M

-8M

Pretax income

-70M

-60M

-179M

-166M

Equity in earnings

Taxes

167K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-70M

-60M

-179M

-166M

BioXcel Therapeutics, Inc. (BTAI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioXcel Therapeutics, Inc. (BTAI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BioXcel Therapeutics, Inc. (BTAI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioXcel Therapeutics, Inc. (BTAI)

Income Statement (Annual)

Income Statement (Annual)